Cargando…
B7‐H5/CD28H is a co‐stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma
B7‐H5 and its cognate receptor CD28H are T lymphocyte second signaling transduction molecules. Here we aimed to explore the function of this pathway in pancreatic cancer in vitro and in vivo, and evaluated the clinical significance in 136 patients with pancreatic ductal adenocarcinoma enrolled from...
Autores principales: | Chen, Qi, Wang, Jianxin, Chen, Wei, Zhang, Qi, Wei, Tao, Zhou, Yue, Xu, Xingyuan, Bai, Xueli, Liang, Tingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361571/ https://www.ncbi.nlm.nih.gov/pubmed/30548441 http://dx.doi.org/10.1111/cas.13914 |
Ejemplares similares
-
OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo
por: Zhi, Xiao, et al.
Publicado: (2015) -
Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
por: MacCurtain, Benjamin M., et al.
Publicado: (2021) -
Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells
por: Lao, Mengyi, et al.
Publicado: (2021) -
Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma
por: Wang, Yunchao, et al.
Publicado: (2017) -
PRSS1 genotype is associated with prognosis in patients with pancreatic ductal adenocarcinoma
por: Wu, Huasheng, et al.
Publicado: (2020)